Skip to content

H.R. 1060 · 119th Congress (2025–2027)

Modern Authentication of Pharmaceuticals Act of 2025

This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable.

The bill applies to products manufactured beginning five years after the bill's enactment.

Show official title

To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 1060’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Donald G. Davis (D-NC-1)
Cosponsors
3 cosponsors

2 original · 1 later

  1. Rep. Don Bacon (R-NE-2)· Original · Feb 6, 2025
  2. Rep. John H. Rutherford (R-FL-5)· Original · Feb 6, 2025
  3. Rep. Brian K. Fitzpatrick (R-PA-1)· Later · Mar 11, 2025
Policy area
Health
Subjects
  • Drug safety, medical device, and laboratory regulation
  • Drug trafficking and controlled substances
  • Prescription drugs
  • Supply chain

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Feb 6, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Modern Authentication of Pharmaceuticals Act of 2025

    Display title, Short title · Introduced in House

  2. To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.

    Official title · Introduced in House